$ABX Company News Gold miner stocks dive, again, to

New Post Public Reply Private Reply Replies (0) Message Board

Nov 25, 2014 at 9:38 AM

$ABX Company News

Gold miner stocks dive, again, to multi-year lows 10:33 a.m. Oct. 31, 2014 - Tomi Kilgore
Gold mining stocks headed for another beating 8:01 a.m. Oct. 31, 2014 - Tomi Kilgore
Investors, it’s finally time to worry about inflation 5:30 a.m. Sept. 5, 2014 - Michael Brush
Freeport-McMoRan’s sale of Chile mine hits tax snag 3:02 p.m. Aug. 29, 2014 - Alistair MacDonald
Goldcorp swings to profit, lowers cost guidance 7:53 a.m. July 31, 2014 - MarketWatch.com
Newmont Mining gearing up for a big breakout 1:56 p.m. July 10, 2014 - blogs.marketwatch.com
Skipping the obvious when investing in Chile 10:10 a.m. July 10, 2014 - The Trading Deck
Fourteen stocks for 2014 halftime report 10:49 a.m. July 8, 2014 - The Trading Deck
Gold might be up this year, but it’s worth only $800 9:52 a.m. July 7, 2014 - Mark Hulbert
Gold miners are stuck in a 'cycle of value destruction' 10:31 a.m. May 29, 2014 - blogs.marketwatch.com
Gold falls 1%, settles at more than one-week low 1:33 p.m. May 1, 2014 - Myra P. Saefong
Barrick Gold profit slumps 90% amid failed merger 1:45 a.m. May 1, 2014 - MarketWatch.com
Barrick gold first-quarter profit slumps 90% 6:40 p.m. April 30, 2014 - MarketWatch.com
Gold falls for the session, gains for the month 2:01 p.m. April 30, 2014 - Myra P. Saefong
Barrick Gold wins vote on pay, overcoming critics 1:24 p.m. April 30, 2014 - MarketWatch.com
Plug Power tanks on fuel-cell criticism; Pfizer gains 2:47 p.m. April 28, 2014 - Sue Chang
Gold settles back under $1,300 an ounce 1:17 p.m. April 28, 2014 - Myra P. Saefong
Barrick, Newmont end merger talks 8:46 a.m. April 28, 2014 - MarketWatch.com
Newmont falls after it ends Barrick merger talks 6:59 a.m. April 28, 2014 - Saumya Vaishampayan
Newmont falls 5.6%; Barrick inches down 0.4%. 6:49 a.m. April 28, 2014 - Saumya Vaishampayan

What It Really Costs To Mine Gold: The Yamana Third Quarter Edition 2:44 a.m. Today - Seeking Alpha
What It Really Costs To Mine Gold: The Yamana Gold Third Quarter Edition 2:44 a.m. Today - Seeking Alpha
Update: Barrick To Appoint Shaun Usmar As CFO 5:50 a.m. Nov. 24, 2014 - Seeking Alpha
Finding Gold Dollars In Nevada: Thomas Drolet 11:10 p.m. Nov. 20, 2014 - Seeking Alpha
Barrick Gold (ABX) Stock Rises Today After JP Morgan's Gold Research Note 4:09 p.m. Nov. 20, 2014 - TheStreet.com
J.P. Morgan likes three pair trades in volatile gold mining sector 3:13 p.m. Nov. 20, 2014 - Seeking Alpha
Hottest Basic Materials Stocks Now – PAAS RGLD CCJ ABX 12:15 p.m. Nov. 20, 2014 - InvestorPlace.com
Update: African Barrick Gold Taking Another Step To Shed Its Past 1:27 a.m. Nov. 20, 2014 - Seeking Alpha
3 Stocks Pushing The Basic Materials Sector Lower 12:16 p.m. Nov. 19, 2014 - TheStreet.com
Biggest Movers in Basic Materials Stocks Now – SIM CCJ NGD BVN 11:30 a.m. Nov. 19, 2014 - InvestorPlace.com
Barrick Gold (ABX) Stock Falls Today After Credit Suisse Issues Bearish Gold Report Through 2015 11:22 a.m. Nov. 19, 2014 - TheStreet.com
Why Falling Indian Jewelry Shares Indicate A Potential Gold Bottom 11:06 a.m. Nov. 19, 2014 - Seeking Alpha
The Future Of Gold - Quantified Mathematical Probabilities 10:42 a.m. Nov. 19, 2014 - Seeking Alpha
Barrick Gold appoints Usmar as CFO designate 5:37 p.m. Nov. 18, 2014 - Seeking Alpha
Gold miners rack up sharp gains as dollar slips 3:59 p.m. Nov. 18, 2014 - Seeking Alpha
Harmony Gold Mining (HMY) Stock Climbing Today as Gold Prices Rally 2:59 p.m. Nov. 18, 2014 - TheStreet.com
Did Gold Mining Stocks Already Bottom? 2:46 p.m. Nov. 18, 2014 - 247WallSt.com
Hottest Basic Materials Stocks Now – KGC GFI AUY ABX 2:30 p.m. Nov. 18, 2014 - InvestorPlace.com
Barrick Gold: The Ultimate Boom Or Bust 1:57 p.m. Nov. 18, 2014 - Seeking Alpha
Why Barrick Gold, Potash and Sony Are 3 of Today’s Best Stocks 11:16 a.m. Nov. 18, 2014 - InvestorPlace.com

Inca One Continues Strategic Hiring at Chala One Plant in Peru 8:32 a.m. Today - Marketwired
Barrick Announces Finance Leadership Transition 4:57 p.m. Nov. 19, 2014 - Marketwired
Malbex Q4 Update 4:31 p.m. Nov. 14, 2014 - Marketwired
Barrick Appoints Executive Project Director for Pascua-Lama 8:00 a.m. Nov. 13, 2014 - Marketwired
Technical Data on Gold Stocks - Barrick Gold, Kinross Gold, Yamana Gold, Goldcorp, and IAMGOLD 8:55 a.m. Nov. 10, 2014 - PR Newswire - PRF
November 2014 Gold Report 3:36 p.m. Nov. 5, 2014 - ACCESSWIRE
Barrick Reports Third Quarter 2014 Results 4:32 p.m. Oct. 29, 2014 - Marketwired
Barrick Gold Announces Dividend 11:21 a.m. Oct. 29, 2014 - Marketwired
Kinross Reports Temporary Suspension of Mill at Round Mountain Mine 4:01 p.m. Oct. 8, 2014 - Marketwired
Technical Coverage on Gold Stocks - Allied Nevada Gold, AuRico Gold, Barrick Gold, IAMGOLD, and Goldcorp 7:55 a.m. Oct. 7, 2014 - PR Newswire - PRF
Barrick Gold Corporation Third Quarter 2014 Results Release, Conference Call and Webcast 1:01 p.m. Oct. 6, 2014 - Marketwire
Probe Mines Appoints Jamie Sokalsky as Director and Chairman Designate 8:12 a.m. Sept. 16, 2014 - Marketwire
NuLegacy Gold Adds Directors 4:31 a.m. Sept. 16, 2014 - Marketwire
Barrick Named Mining Industry Leader by the Dow Jones Sustainability Index 8:34 a.m. Sept. 15, 2014 - Marketwire
Barrick Named Mining Industry Leader by the Dow Jones Sustainability Index 8:21 a.m. Sept. 15, 2014 - Marketwire
Inca One Hires VP Development and Operations and Appoints New CFO 7:31 a.m. Sept. 9, 2014 - Marketwire
Malbex Resources Inc. Closes Private Placement and Enters Into Earn-In Arrangement With Barrick Gold Corporation on the Del Carmen Project, Argentina 3:57 p.m. Aug. 28, 2014 - Marketwire
Metals and Mining Equities Technical Coverage -- Banro, Kinross Gold, Barrick Gold, AK Steel Holding, and CiaSiderurgica Nacional 8:00 a.m. Aug. 26, 2014 - PR Newswire - PRF
Alaska's Power Industry Weighs $8 Billion in Projects, an Industrial Info News Alert 5:15 a.m. Aug. 25, 2014 - Marketwire
Terraco Gold Reports on Significant Upgrade in Resource and 2014 Budget Increase Released by Midway Gold on the Spring Valley Gold Project, Nevada 6:31 a.m. Aug. 13, 2014 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...